Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 06/06/2025 | PUT | $23.00 | 9,488 | +2,815 | +42.18% |
| 12/18/2026 | CALL | $23.00 | 2,576 | +1,524 | +144.87% |
| 06/13/2025 | PUT | $23.00 | 5,046 | +1,253 | +33.03% |
| 09/19/2025 | PUT | $12.00 | 2,747 | +1,199 | +77.45% |
| 03/20/2026 | PUT | $20.00 | 8,071 | +1,110 | +15.95% |
| 07/03/2025 | PUT | $23.00 | 1,019 | +791 | +346.93% |
| 06/20/2025 | CALL | $25.00 | 110,924 | -385 | -0.35% |
| 09/19/2025 | PUT | $23.00 | 34,489 | -938 | -2.65% |
| 06/06/2025 | PUT | $24.50 | 7,713 | -1,412 | -15.47% |
| 12/18/2026 | PUT | $15.00 | 17,717 | -1,836 | -9.39% |
| 06/20/2025 | PUT | $26.00 | 13,329 | -2,801 | -17.37% |
| 06/20/2025 | PUT | $25.00 | 51,533 | -3,898 | -7.03% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.02% | 170.64M | 6.14B |
| Vanguard 500 Index Fund | 2.30% | 129.76M | 4.67B |
| Washington Mutual Investors Fund | 1.42% | 80.41M | 2.89B |
| Fidelity 500 Index Fund | 1.09% | 61.54M | 2.21B |
| SPDR S&P 500 ETF Trust | 1.08% | 60.77M | 2.19B |
| American Balanced Fund | 1.00% | 56.61M | 2.04B |
| Income Fund of America Inc | 0.93% | 52.68M | 1.9B |
| iShares Core S&P 500 ETF | 0.89% | 50.1M | 1.8B |
| Vanguard Index-Value Index Fund | 0.86% | 48.51M | 1.75B |
| Vanguard Specialized-Health Care Fund | 0.86% | 48.32M | 1.74B |
Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)
06/06 07:00 am
GlobeNewswire Inc.
Read moreArvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
06/06 07:00 am
GlobeNewswire Inc.
Read moreBetter High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis
06/05 03:34 am
The Motley Fool
Read moreHere Are All 6 Stocks I've Bought Through 5 Months of 2025
06/05 03:06 am
The Motley Fool
Read moreStarke Verkaufszahlen für Cresemba® (Isavuconazol) in der Region Asien-Pazifik und China lösen weitere Meilensteinzahlung an Basilea aus
06/05 01:15 am
GlobeNewswire Inc.
Read moreStrong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea
06/05 01:15 am
GlobeNewswire Inc.
Read more3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June
06/03 03:06 am
The Motley Fool
Read moreCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
06/02 04:00 pm
GlobeNewswire Inc.
Read moreTerrible News for Pfizer Stock Investors
06/01 09:15 am
The Motley Fool
Read moreBeat the S&P 500 With This Cash-Gushing Dividend Stock
06/01 04:14 am
The Motley Fool
Read moreThe World Market for Smoking Cessation & Nicotine De-Addiction Products 2025-2030: Precision Counseling, Targeted Pharmacogenomic Therapies, and Resilient Supply Chains Present Lucrative Opportunities
05/30 04:56 am
GlobeNewswire Inc.
Read morePenicillin Market Research Report 2025 - Global $12.5+ Bn Trends, Opportunities, and Forecasts, 2020-2030F
05/29 10:58 am
GlobeNewswire Inc.
Read morePfizer's Mega Deal Highlights China's Rising Role In Global Pharma
05/29 09:38 am
Benzinga
Read moreNovo Nordisk's 52% Plunge: Is the Company Fumbling Its Leadership in the $150 Billion Weight Loss Market?
05/28 04:15 am
The Motley Fool
Read moreLiposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight
05/27 01:00 pm
GlobeNewswire Inc.
Read moreSchizophrenia Drugs Market Research Report 2025-2035: Advances in Antipsychotic Drug Development, Increasing Prevalence, & Greater Awareness and Access to Mental Health Care Bolster Growth
05/27 10:56 am
GlobeNewswire Inc.
Read moreMadison Realty Capital Originates $720 Million Loan for Office-to-Residential Conversion of Former Pfizer Headquarters
05/25 06:00 pm
GlobeNewswire Inc.
Read moreInvesting for Passive Income? Here's What History Says About the Stability of Dividend King Stocks.
05/25 04:10 am
The Motley Fool
Read moreU.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
05/24 04:11 am
The Motley Fool
Read morePfizer's 7.5% Dividend: Income Haven or House of Cards?
05/23 05:11 pm
Investing.com
Read moreCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
05/23 04:00 pm
GlobeNewswire Inc.
Read moreAplastic Anemia Global Clinical Trials Review, 2025 | Explore Trends and Enrollment Data in Aplastic Anemia Clinical Trials
05/20 06:59 am
GlobeNewswire Inc.
Read moreBio/Pharmaceutical Outsourcing Report, March 2025 Edition - Trump Tariffs Drive Pharma Manufacturing to US but Risk Inflation and Disruption
05/19 10:56 am
GlobeNewswire Inc.
Read moreIterum Therapeutics Announces Extension of Term of Promissory Note
05/19 07:00 am
GlobeNewswire Inc.
Read moreDon't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
05/18 12:05 pm
The Motley Fool
Read more3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever
05/14 06:05 pm
The Motley Fool
Read moreSaudi Arabia Active Pharmaceutical Ingredients Market Forecasts & Opportunities Report 2024-2025 & 2030 Featuring Pfizer, Aurobindo Pharma, Novartis, BASF, Viatris, and Novo Nordisk
05/13 04:59 am
GlobeNewswire Inc.
Read moreSaudi Arabia Pharmaceutical CDMO Market Research Report 2025 Featuring Tabuk Manufacturing, Lifera, Saudi Bio, Fresenius Kabi, Hikma Pharma, Pfizer, Novartis
05/13 04:46 am
GlobeNewswire Inc.
Read moreFaruqi & Faruqi Reminds Cerevel Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - CERE
05/11 08:29 am
GlobeNewswire Inc.
Read moreGeneric Oncology Drugs Market Size Estimated to Reach USD 30,998 Mn by 2034, Rising Global Cancer Cases Increase Demand for Affordable Treatments
05/07 11:00 am
GlobeNewswire Inc.
Read moreGiants of Cancer Care® announces the 13th annual class of inductees
05/07 09:00 am
GlobeNewswire Inc.
Read morePharmaceutical CDMO Market Set to Surpass $315.08 Billion by 2034, Driven by 7.24% CAGR
05/06 10:00 am
GlobeNewswire Inc.
Read moreWhy Viking Therapeutics Stock Surged Nearly 20% Higher in April
05/06 04:33 am
The Motley Fool
Read moreCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
05/02 04:00 pm
GlobeNewswire Inc.
Read moreLiver Cancer Treatment Market is expected to generate a revenue of USD 8.88 Billion by 2031, Globally, at 13.45% CAGR: Verified Market Research®
05/02 10:00 am
GlobeNewswire Inc.
Read more3 No-Brainer Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought in May
05/02 03:51 am
The Motley Fool
Read more3 High-Yield Dividend Stocks That Could Rally Near 52-Week Lows
05/01 01:17 pm
Investing.com
Read moreMetastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight
04/30 01:00 pm
GlobeNewswire Inc.
Read moreThis High-Yield Pharma Stock Looks Like an Incredible Bargain
04/30 06:45 am
The Motley Fool
Read morePfizer's Dividend Yield Is 7.5%. Is It Still Safe?
04/30 06:15 am
The Motley Fool
Read moreWill Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
04/30 04:51 am
The Motley Fool
Read morePrediction: Pfizer's Loss May Be Viking Therapeutics' Gain
04/30 03:15 am
The Motley Fool
Read morePfizer's Covid Windfall Shrinks, Expands Cost-Cutting Efforts
04/29 11:31 am
Benzinga
Read moreNurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs
04/28 04:00 pm
GlobeNewswire Inc.
Read more3 Dividend Stocks to Buy and Hold for the Next Decade
04/28 07:47 am
The Motley Fool
Read moreINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel Therapeutics
04/26 09:50 am
GlobeNewswire Inc.
Read moreCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
04/25 04:00 pm
GlobeNewswire Inc.
Read moreGuardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform
04/24 03:36 pm
Benzinga
Read more5 All-Weather Dividend Stocks to Buy Right Now
04/24 08:30 am
The Motley Fool
Read more